If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 141 - 150 of 269
A Multicenter, Adaptive, Randomized, Controlled, Trial Platform to Evaluate Safety and Efficacy Strategies and Treatments for Hospitalized Patients with Respiratory Infections
Objective
Safety, Efficacy and Tx Strategies for Hospitalized Patients with Respiratory Infections
Protocol No
INF-NIAID-STRIVE
Categories
An Open-Label, Phase 1/2 Study of JCAR017 in Subjects with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (017004)
Objective
Study Evaluating Safety and Efficacy of JCAR017 in Subject with rrCLL or SLL
Protocol No
JUNO-017004-TRANSCEND-CLL
Categories
Targeted Axillary Dissection and Deep Learning Radiomics To Predict Axillary Nodal Burden Pre-Operatively in HR+/Her2-, Node-Positive Breast Cancer Undergoing Upfront Surgery
Objective
De-Escalating Axillary Surgery in Node-Positive HR Positive Subjects Who Undergo Upfront Surgery
Protocol No
MDACC-RADIOMICS
Categories
A Phase 2/3, Multicenter, Randomized, Active-Controlled, Open-label Study to Evaluate the Efficacy and Safety of Zanubrutinib in Patients With Primary Membranous Nephropathy
Objective
Zanubrutinib in Primary Membranous Nephropathy
Protocol No
NEPH-BEIGENE-BGB-3111-309
Categories
A Phase 2/3 Adaptive, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of VX-147 in Subjects Aged 12 Years and Older With APOL1-mediated Proteinuric Kidney Disease
Objective
VX-147 in APOL1- Mediated Proteinuric Kidney Disease
Protocol No
NEPH-VERTEX-VX21-147-301
Categories
Effects of Transcranial Direct Current Stimulation (tDCS) on Language
Objective
Effects of Transcranial Direct Current Stimulation (tDCS) on Language
Protocol No
NEURO-AHW-TDCS-LANGUAGE
Categories
A Long-Term, Prospective, Observational, Registry of Patients with Anti-Aquaporin 4 Antibody-Positive (AQP4+) Neuromyelitis Optica Spectrum Disorder (NMOSD) Treated with Alexion Complement Component 5 (C5) Inhibitor Therapies (ALXN-C5IT)
Objective
Registry of Patients with AQP4+ NMOSD Treated with Alexion C5 Inhibitor Therapies
Protocol No
NEURO-ALEXION-ALX-NMO-501
A Phase 3 Double-blind, Randomized, Placebo-controlled, Multi-center Trial to Evaluate the Efficacy and Safety of AR1001 Over 52 Weeks in Participants With Early Alzheimer's Disease (Polaris-AD)
Objective
AR1001 in Participants With Early Alzheimer's Disease
Protocol No
NEURO-ARIBIO-POLARIS-AD
A Prospective, Observational Study of Bafiertam Evaluating Persistence on Treatment, Safety, Tolerability, And Effectiveness In Routine Clinical Practice
Objective
Observational Study of Bafiertam Treatment In Routine Clinical Practice SIMPLE
Protocol No
NEURO-BANNER-SIMPLE
A Multicenter, International, Randomized, Placebo Controlled, Double-Blind, Parallel Group And Event Driven Phase 3 Study Of The Oral Fxia Inhibitor Asundexian (BAY 2433334) For The Prevention Of Ischemic Stroke In Male And Female Participants Aged 1
Objective
A Study to Learn More About Asundexian (Also Called BAY2433334) for Prevention of Ischemic Stroke in Male and Female Participants Aged 18 Years and Older Who Already Had Such a Stroke Due to a Blood Clot That Formed Outside the Heart and Travelled to the Brain, or Temporary Stroke-like Symptoms
Protocol No
NEURO-BAYER-OCEANIC-STROKE
Categories